LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that it is finalizing scheduling details for an exclusive live-streamed interview with Hablemos Seguros & Finanzas, a Venezuelan business, finance, and insurance media platform. The interview is expected to occur in the near term, with additional details regarding timing and publication to be announced once finalized.
According to the Company, the interview will focus on LataMed AI’s healthcare technology development initiatives, telehealth infrastructure efforts, artificial intelligence applications within healthcare environments, and the broader strategy for developing digital healthcare technologies designed for emerging markets throughout Latin America. The discussion aims to provide an opportunity for management to discuss recent operational developments, technology initiatives under development, and long-term strategy for building platforms intended to support patients, providers, and healthcare organizations.
The Company believes the interview will serve as a timely platform to communicate its strategic objectives, increase awareness of its digital healthcare development efforts, and engage with industry participants and healthcare stakeholders regarding the evolving role of technology-enabled healthcare solutions in Latin America. Topics are expected to include telehealth infrastructure, healthcare coordination technologies, emergency medical response initiatives, pharmacy integration capabilities, and AI-driven healthcare solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We believe this interview represents a valuable opportunity to communicate LataMed AI’s strategic vision, technology development priorities, and commitment to advancing digital healthcare infrastructure across Latin America. As healthcare systems continue to evaluate technology-enabled models for coordination, access, and efficiency, we remain focused on developing practical solutions designed to support patients, providers, and healthcare organizations in emerging markets.”
The interview is expected to be live-streamed through the media platform’s digital channels, with a recording to be made available on the Company’s website shortly after its conclusion. Availability, timing, and distribution remain subject to final scheduling and production arrangements.
For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
